Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rosso

Showing results (361-370 of 478) with videos related to

Pageof 48
Sort By:
Haematologica|January 1, 1984
Malignant lymphoma with hairy cells and IgM paraprotein. Splenic homing of secreting cellsP Spriano, A Baraldi, G Barosi, et al.
Cancer Investigation|January 1, 1988
Cisplatin and etoposide as second-line chemotherapy in patients with small cell lung cancerF Figoli, A Veronesi, A Ardizzoni, et al.
Breast Cancer Research and Treatment|March 11, 1998
Tamoxifen and the endometrium: findings of pelvic ultrasound examination and endometrial biopsy in asymptomatic breast cancer patientsG Bertelli, M Venturini, L Del Mastro, et al.
Cancer|October 15, 1994
Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapyM Venturini, L Del Mastro, G Melioli, et al.
British Journal of Cancer|February 1, 1989
Phase II study of lonidamine in metastatic breast cancerP Pronzato, D Amoroso, G Bertelli, et al.
Tumori|April 30, 1988
Carboplatin (JM 8), adriamycin and cyclophosphamide (JAC) in advanced ovarian carcinoma: a pilot studyP F Conte, M Bruzzone, S Chiara, et al.
Oncology|June 26, 2004
Patterns of relapse and modalities of treatment of breast cancer: the 'IRIS' Project, a multicenter observational studyM Cazzaniga, P Pronzato, S L Leto di Priolo, et al.
Haematologica|May 1, 1991
Hodgkin's disease: update of findingsS Pileri, E Sabattini, P L Tazzari, et al.
American Journal of Clinical Oncology|December 1, 1993
Second-line hormonotherapy for breast cancer. Uselessness of first-line continuationP Pronzato, A Rubagotti, D Amoroso, et al.
International Journal of Antimicrobial Agents|November 25, 2000
Tolerance of highly active antiretroviral therapy in HIV patients: a 3-year follow upA Beltrame, V Del Bono, M Marturano, et al.
Pageof 48

Showing results (361-370 of 478) with videos related to

Sort By:
Pageof 48
Haematologica|January 1, 1984
Malignant lymphoma with hairy cells and IgM paraprotein. Splenic homing of secreting cellsP Spriano, A Baraldi, G Barosi, et al.
Cancer Investigation|January 1, 1988
Cisplatin and etoposide as second-line chemotherapy in patients with small cell lung cancerF Figoli, A Veronesi, A Ardizzoni, et al.
Breast Cancer Research and Treatment|March 11, 1998
Tamoxifen and the endometrium: findings of pelvic ultrasound examination and endometrial biopsy in asymptomatic breast cancer patientsG Bertelli, M Venturini, L Del Mastro, et al.
Cancer|October 15, 1994
Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapyM Venturini, L Del Mastro, G Melioli, et al.
British Journal of Cancer|February 1, 1989
Phase II study of lonidamine in metastatic breast cancerP Pronzato, D Amoroso, G Bertelli, et al.
Tumori|April 30, 1988
Carboplatin (JM 8), adriamycin and cyclophosphamide (JAC) in advanced ovarian carcinoma: a pilot studyP F Conte, M Bruzzone, S Chiara, et al.
Oncology|June 26, 2004
Patterns of relapse and modalities of treatment of breast cancer: the 'IRIS' Project, a multicenter observational studyM Cazzaniga, P Pronzato, S L Leto di Priolo, et al.
Haematologica|May 1, 1991
Hodgkin's disease: update of findingsS Pileri, E Sabattini, P L Tazzari, et al.
American Journal of Clinical Oncology|December 1, 1993
Second-line hormonotherapy for breast cancer. Uselessness of first-line continuationP Pronzato, A Rubagotti, D Amoroso, et al.
International Journal of Antimicrobial Agents|November 25, 2000
Tolerance of highly active antiretroviral therapy in HIV patients: a 3-year follow upA Beltrame, V Del Bono, M Marturano, et al.
Pageof 48